Biden Administration Throws Down Its First Gauntlet on 340B
By EsqSocial Corporation 19/05/21
On May 17, 2021, the Biden Administration took its first major action impacting the 340B Drug Discount Program. In a forceful statement, the Administration made plain its views on a major controversy that has pitted drug manufacturers against 340B covered entities for the past year - proclaiming that drug manufacturers are violating the 340B statute by restricting covered entity access to 340B discounts for drugs dispensed through 340B contract pharmacies....
By: Mintz - Health Care Viewpoints